Kageyama Shinichi 影山愼一

… Alternative Names

Researcher Number	80194695
Other IDs
Affiliation (Current)	2020: 三重大学, 医学系研究科, リサーチアソシエイト
Affiliation (based on the past Project Information) *help	2019: 三重大学, 医学系研究科, 教授 2016 – 2017: 三重大学, 医学系研究科, 教授 2014 – 2015: 三重大学, 医学(系)研究科(研究院), 教授 2012 – 2013: 三重大学, 医学(系)研究科(研究院), 准教授 2009 – 2011: Mie University, 大学院・医学系研究科, 准教授 … More
Review Section/Research Field	Principal Investigator Digestive surgery / Otorhinolaryngology / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields Except Principal Investigator Biological Sciences
Keywords	Principal Investigator がんワクチン / 食道癌 / 免疫モニタリング / 臨床試験 / 複合的がん免疫療法 / TCR遺伝子導入細胞療法 / CAR-T療法 / TCR遺伝子導入T細胞 / CAR-T細胞 / MAGE-A4 … More Except Principal Investigator … More

T cell optimization for effective CAR-T cell therapy to refractory esophageal cancerPrincipal InvestigatorOngoing
- Principal Investigator
  
  影山愼一
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Mie University
Optimization of cancer vaccine that are combined with TCR-gene transduced T cell transfer for esophageal cancerPrincipal Investigator
- Principal Investigator
  
  Kageyama Shinichi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Mie University
Spreading immune-reactions in esophageal cancer patients who were given cancer vaccine and whose tumors co-express additional antigensPrincipal Investigator
- Principal Investigator
  
  KAGEYAMA Shinichi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Mie University
Immunomonitoring in head and neck cancer patients treated with protein vaccine through tumor destructionPrincipal Investigator
- Principal Investigator
  
  KAGEYAMA Shinichi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Mie University
Polyvalent cancer vaccine
- Principal Investigator
  
  SHIKU Hiroshi
- Project Period (FY)
  2005 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Mie University
がん遺伝子産物由来ペプチド抗原によるがん治療
- Principal Investigator
  
  SHIKU Hiroshi
- Project Period (FY)
  2000 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Mie University

[Book] Immunotyerapy of Cancer（分担）2016
- Author(s)
  Shinichi Kageyama
- Total Pages
  358
- Publisher
  Springer
- Data Source
  KAKENHI-PROJECT-15K10093
[Book] がん免疫療法-実用化へのチャレンジ2010
- Author(s)
  影山愼一
- Total Pages
  250
- Publisher
  シーエムシー出版
- Data Source
  KAKENHI-PROJECT-21592191
[Book] がん免疫療法-実用化へのチャレンジ-2010
- Author(s)
  影山愼一
- Publisher
  シーエムシー出版
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high grade soft tissue sarcoma2019
- Author(s)
  Kakimoto T, Matsumine A, Kageyama S, Asanuma K, Matsubara T, Nakamura T, Iino T, Ikeda H, Shiku H, Sudo A
- Journal Title
  
  Oncol Lett
  
  Volume: 17 Pages: 3937-3943
- DOI
  10.3892/ol.2019.10044
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-16K10856
[Journal Article] Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination2018
- Author(s)
  Abiko Takehiro、Tsuchikawa Takahiro、Miyauchi Kengo、Wada Masataka、Kyogoku Noriaki、Shichinohe Toshiaki、Miyahara Yoshihiro、Kageyama Shinichi、Ikeda Hiroaki、Shiku Hiroshi、Hirano Satoshi
- Journal Title
  
  Oncol Lett
  
  Volume: 15 Pages: 3703-3711
- DOI
  10.3892/ol.2018.7767
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Cancer immunotherapy using gene-engineered T cells2018
- Author(s)
  影山　愼一
- Journal Title
  
  Jpn. J. Clin. Hematol.
  
  Volume: 59 Issue: 2 Pages: 216-224
- DOI
  10.11406/rinketsu.59.216
- NAID
  130006441932
- ISSN
  0485-1439, 1882-0824
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10093
[Journal Article] Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination2018
- Author(s)
  Wada M, Tsuchikawa T, Kyogoku N, Abiko T, Miyauchi K, Takeuchi S, Kuwatani T, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S
- Journal Title
  
  Anticancer Res
  
  Volume: 38 Pages: 1435-1444
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10093
[Journal Article] Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy2017
- Author(s)
  Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K
- Journal Title
  
  Clin Breast Cancer
  
  Volume: S1526-8209 Pages: 507-511
- DOI
  10.1016/j.clbc.2017.05.013
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10093
[Journal Article] Safety and persistence of WT1-specific T-cell receptor gene－transduced lymphocytes in patients with AML and MDS2017
- Author(s)
  Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.
- Journal Title
  
  Blood
  
  Volume: 130 Pages: 1985-1994
- DOI
  10.1182/blood-2017-06-791202
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09307, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-17K09949, KAKENHI-PROJECT-17K09957, KAKENHI-PROJECT-15H04858, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K09497, KAKENHI-PROJECT-15K09498, KAKENHI-PROJECT-15K09506, KAKENHI-PROJECT-15K10093
[Journal Article] Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume by Modification of the Default Apheresis Setting2017
- Author(s)
  Tanaka Y, Ohishi K, Sawai T, Iwasaki H, Kageyama S, Masuya M, Matsumoto T, Tanigawa T, Wada H, Shiku H, Ito M, Katayama N
- Journal Title
  
  Ther Apher Dial
  
  Volume: 21 Pages: 507-511
- DOI
  10.1111/1744-9987.12562
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08645, KAKENHI-PROJECT-16K09307, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-15K10093
[Journal Article] Clinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination. Immunotherapy2016
- Author(s)
  Miyauchi K, Tsuchikawa T, Wada M, Abiko T, Kyogoku N, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S.
- Journal Title
  
  Immunotherapy
  
  Volume: 印刷中 Pages: 527-40
- DOI
  10.2217/imt-2016-0007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935
[Journal Article] Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel2016
- Author(s)
  Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T, Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, Miyahara Y, Kageyama S, Shiku H, Hirano S.
- Journal Title
  
  Oncol Lett
  
  Volume: 12 Pages: 1193-4504
- DOI
  10.3892/ol.2016.5253
- NAID
  120005981404
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935, KAKENHI-PROJECT-15K10093
[Journal Article] Adoptive transfer of MAGE-A4 T-cell receptor gene－transduced lymphocytes in patients with recurrent esophageal cancer.2015
- Author(s)
  Kageyama S, Ikeda H, Miyahara Y, Imai N, Ishihara M, Saito K, Sugino S, Ueda S, Ishikawa T, Kokura S, Naota H, Ohishi K, Shiraishi T, Inoue N, Tanabe M, Kidokoro T, Yoshioka H, Tomura D, Nukaya I, Mineno J, Takesako K, Katayama N, Shiku H.
- Journal Title
  
  Clin Cancer Res
  
  Volume: in press Pages: 2268-2277
- DOI
  10.1158/1078-0432.ccr-14-1559
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-25350612, KAKENHI-PROJECT-25461413, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-25461447
[Journal Article] High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine.2014
- Author(s)
  Saito T, Wada H, Yamasaki M, Miyata H, Nishikawa H, Sato E, Kageyama S, Shiku H, Mori M, Doki Y.
- Journal Title
  
  Vaccine
  
  Volume: 32 Pages: 5901-5907
- DOI
  10.1016/j.vaccine.2014.09.002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26670581
[Journal Article] Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.2013
- Author(s)
  Hirayama M, Nishikawa H, Nagata Y, Tsuji T, Kato T, Kageyama S, Ueda S, Sugiyama D, Hori S, Sakaguchi S, Ritter G, Old LJ, Gnjatic S, and Shiku H
- Journal Title
  
  Eur J Immunol.
  
  Volume: 43 (4) Pages: 989-1000
- DOI
  10.1002/eji.201242800
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-24591965, KAKENHI-PROJECT-25670553
[Journal Article] Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.2013
- Author(s)
  Kageyama S, Wada H, Muro K, Niwa Y, Ueda S, Miyata H, Takiguchi S, Sugino SH, Miyahara Y, Ikeda H, Imai N, Sato E, Yamada T, Osako M, Ohnishi M, Harada N, Hishida T, Doki Y, Shiku H
- Journal Title
  
  J Transl Med
  
  Volume: 5;11 Pages: 246-246
- DOI
  10.1186/1479-5876-11-246
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501284, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-24591965, KAKENHI-PROJECT-24650259
[Journal Article] CHPがん蛋白ワクチン2011
- Author(s)
  影山愼一
- Journal Title
  
  腫瘍内科
  
  Volume: 8巻 Pages: 446-451
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] 治療用がんワクチン開発のためのFDAからのガイダンス2011
- Author(s)
  影山愼一
- Journal Title
  
  腫瘍内科
  
  Volume: 8巻 Pages: 167-171
- NAID
  40018983468
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] 抗腫瘍ワクチン2010
- Author(s)
  影山愼一
- Journal Title
  
  日本臨床
  
  Volume: 68 Pages: 1100-1104
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia2010
- Author(s)
  Ohtake S, Miyawaki S, Kiyoi H, Miyazaki Y, Okumura H, Matsuda S, Nagai T, Kishimoto Y, Okada M, Takahashi M, Handa H, Takeuchi J, Kageyama S, Asou N, Yagasaki F, Maeda Y, Ohnishi K, Naoe T
- Journal Title
  
  JALSG AML95 study Int J Hematol
  
  Volume: 91 Pages: 276-283
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study2010
- Author(s)
  Ohtake S, Miyawaki S, Kiyoi H, Miyazaki Y, Okumura H, Matsuda S, Nagai T, Kishimoto Y, Okada M, Takahashi M, Handa H, Takeuchi J, Kageyama S, Asou N, Yagasaki F, Maeda Y, Ohnishi K, Naoe T, Ohno R
- Journal Title
  
  Int J Hematol (印刷中)
- NAID
  10026111520
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.2009
- Author(s)
  Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
- Journal Title
  
  Vaccine 27(49)
  
  Pages: 6854-6861
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016031
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patientsvaccinated with combinations of cholesteryl pullulan(CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
- Author(s)
  Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
- Journal Title
  
  Vaccine
  
  Volume: 27 Pages: 6854-6861
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
- Author(s)
  Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
- Journal Title
  
  Vaccine 47
  
  Pages: 6854-6861
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592191
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
- Author(s)
  Aoki M., Ueda S., Nishikawa H., Kitano S., Hirayama M., Ikeda H., Toyoda H., Tanaka K., Kanai M., Takabayashi A., Imai H., Shiraishi T., Sato E., Wada H., Nakayama E., Takei Y., Katayama N., Shiku H., Kageyama S
- Journal Title
  
  Vaccine 27
  
  Pages: 6854-61
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016031
[Journal Article] Humoral immune responses in patients vaccinated with 1-146 HER2 Protein complexed with cholesteryl pullulan nanogel(CHP-HER2)2008
- Author(s)
  Kageyama S., Kitano S., Hirayama M., Nagata Y., Imai H., Shiraishi T., Akiyoshi K., Scott A., Murphy R., Hoffman E., Old L., Katayama N., Shiku H
- Journal Title
  
  Cancer Science 99
  
  Pages: 601-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016031
[Journal Article] Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel (CHP-HER2)2008
- Author(s)
  Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott A, Murphy R, Hoffman E, Old, L, Katayama N, Shiku H
- Journal Title
  
  Cancer Science 99(3)
  
  Pages: 601-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016031
[Journal Article] HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan2006
- Author(s)
  Kitano S., Kageyama S., Nagata Y., Miyahara Y., Hiasa A., Naota H., Okumura S., Imai H., Shiraishi T., Masuya M., Nishikawa M., Sunamoto J., Akiyoshi K., Kanematsu T., Scott AM., Murphy R., Hoffman EW., Old LJ., Shiku H
- Journal Title
  
  Clin. Cancer Res 12
  
  Pages: 7397-405
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016031
[Presentation] MAGE-A4及びNY-ESO-1抗原特異的 TCR遺伝子改変T細胞輸注療法の臨床試験2017
- Author(s)
  影山　愼一
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen2017
- Author(s)
  影山　愼一
- Organizer
  59th ASH Annual Meeting & Exposition 第59回米国血液学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] 食道癌に対するがんワクチンとT細胞療法の臨床試験2017
- Author(s)
  影山　愼一
- Organizer
  第15回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] Clinical trials of adoptive transfer of TCR-modified T cell therapy for refractory cancer2017
- Author(s)
  影山　愼一
- Organizer
  8th Annual Meeting of Asian Cellular Therapy Organization 第8回アジア細胞療法学会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] 治療抵抗性固形腫瘍を対象とした NY-ESO-1及びMAGE-A4を標的にするTCR遺伝子導入 T細胞輸注療法の臨床試験2017
- Author(s)
  影山　愼一
- Organizer
  第23回日本遺伝子細胞治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] 食道癌に対する免疫療法：がんワクチンと免疫細胞治療2016
- Author(s)
  影山愼一
- Organizer
  第70回日本食道学会学術集会
- Place of Presentation
  ザ・プリンスパークタワー東京（東京都・港区）
- Invited
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] 滑膜肉腫に対するTCR改変T細胞を用いた免疫細胞輸注療法2015
- Author(s)
  影山愼一　松峯昭彦
- Organizer
  第53回日本癌治療学会学術総会
- Place of Presentation
  国立京都国際会館（京都府・京都市）
- Year and Date
  2015-10-31
- Invited
- Data Source
  KAKENHI-PROJECT-15K10093
[Presentation] 食道癌に対する免疫療法―がんワクチンと免疫細胞療法―2014
- Author(s)
  影山愼一
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡国際会議場（福岡市）
- Year and Date
  2014-07-19
- Invited
- Data Source
  KAKENHI-PROJECT-24591939
[Presentation] TCR-gene engineered T cell transfer as a treatment for refractory esophageal cancer2014
- Author(s)
  影山愼一
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡国際会議場（福岡市）
- Year and Date
  2014-07-18
- Invited
- Data Source
  KAKENHI-PROJECT-24591939
[Presentation] Immune responses and survival benefits of esophageal cancer patients vaccinated with NY-ESO-1(CHP-NY-ESO-1); P1 trial2013
- Author(s)
  影山愼一
- Organizer
  第11回日本臨床腫瘍学会総会
- Place of Presentation
  仙台市
- Data Source
  KAKENHI-PROJECT-24591939
[Presentation] 大学発トランスレーショナルリサーチの経験から2012
- Author(s)
  影山愼一、珠玖　洋
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-24591939
[Presentation] 疎水化多糖・タンパクがんワクチンTRからのレッスン2011
- Author(s)
  影山愼一
- Organizer
  第49回日本癌治療学会学術総会
- Place of Presentation
  名古屋市
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] 疎水化多糖・タンパクがんワクチンTRからのレッスン2011
- Author(s)
  影山愼一
- Organizer
  第49回日本癌治療学会学術総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] CHP-抗原蛋白のがんワクチン橋渡し研究2011
- Author(s)
  影山愼一
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  熊本市
- Year and Date
  2011-07-22
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] MAGE-A4抗原を発現する非小細胞性肺癌細胞株におけるMAGE-A4発現の検討2010
- Author(s)
  影山愼一, 他
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪市
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] CHP-抗原がんワクチンのトランスレーショナルリサーチを通じた得られた成果と課題2010
- Author(s)
  影山愼一
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  北九州市
- Year and Date
  2010-06-24
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] MAGE-A4抗原を発現する難治性悪性腫瘍に対するCHP-MAGE-A4がんワクチン臨床試験(第I+II相試験)2010
- Author(s)
  京極典憲、影山愼一
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪市
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] MAGE-A4抗原を発現する難治性悪性腫瘍に対するCHP-MAGE-A4がんワクチン臨床試験(第I+ II相試験)2010
- Author(s)
  影山愼一, 他
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪市
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] OK-432を用いたCHP-NY-ESO-1蛋白ワクチンにより誘導されたCD4+ T細胞の解析2009
- Author(s)
  影山愼一, 他
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  横浜市
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] CHP-蛋白がんワクチンのトランスレーショナルリサーチを通じて得られた成果と課題2009
- Author(s)
  影山愼一
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  北九州市
- Year and Date
  2009-06-24
- Data Source
  KAKENHI-PROJECT-21592191
[Presentation] Combination cancer vaccine of CHP-NY-ESO-1 and CHP-HER2 with immuno-adjuvant, OK-432, for chemorefractory metastatic or recurrent esophageal cancer patients2008
- Author(s)
  Ueda S, Aoki M, Nishikawa H, Hirayama M, Kitano S, Hayashi E, Kanai M, Takabayashi A, Shiku H, Kageyama S
- Organizer
  American Association for Cancer Research 99th Annual Meeting
- Place of Presentation
  San Diego, USA
- Data Source
  KAKENHI-PROJECT-17016031
[Presentation] A clinical trial of CHP-HER2 vaccine with adjuvant GM-CSF:A case representing antigen spreading2007
- Author(s)
  Kitano S, Kageyama S, Nishikawa H, Hirayama M, Hiasa A, Ikeda H, Old LJ, Shiku H
- Organizer
  15th Cancer Research Institute Annual symposium
- Place of Presentation
  NY, USA
- Data Source
  KAKENHI-PROJECT-17016031
[Presentation] Humoral immune responses in patients vaccinated with HER2 protein complexed with a novel antigen delivery system of cholesteryl pullulan(CHP-HER2)2006
- Author(s)
  Kitano S, Hirayama M, Kageyama S, Nagata Y, Nishikawa H, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H
- Organizer
  97TH Annual Meeting of American Association for Cancer Reseach
- Place of Presentation
  Washington DC, USA
- Data Source
  KAKENHI-PROJECT-17016031
[Presentation] NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) provides dose-dependent effects on immune responses and survival benefits for recurrent esophageal cancer patients.
- Author(s)
  影山愼一
- Organizer
  The European Cancer Congress 2013（2013年欧州がん会議）
- Place of Presentation
  アムステルダム（オランダ）
- Data Source
  KAKENHI-PROJECT-24591939

1. SHIKU Hiroshi (80154194)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
2. YUTA Atsushi (80293778)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 渡辺正人 (30220924)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 片山直之 (20185812)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. 宮原慶裕 (10582083)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 加藤琢磨 (60224515)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. IKEDA Hiroaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 7 results
8. SHICHINOHE Toshiaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. HIRANO Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. TSUCHIKAWA Takahiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
11. MASUYA Masahiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
12. FUJIWARA Hiroshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. KOKURA Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. ISHIKAWA Takeshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. OHISHI Kohshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. UEDA Shugo

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
17. KUNIHIRO Asanuma

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 俵功

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. 安川正貴

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. 寺倉精太郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 村田誠

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 西川博嘉

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
23. 原田直純

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 土岐祐一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 和田英夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kageyama Shinichi 影山 愼一

影山 愼一 カゲヤマ シンイチ

KAGEYAMA Shinichi 影山 愼一

影山 慎一 カゲヤマ シンイチ

Research Projects

Research Products

Co-Researchers

T cell optimization for effective CAR-T cell therapy to refractory esophageal cancerPrincipal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Optimization of cancer vaccine that are combined with TCR-gene transduced T cell transfer for esophageal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Spreading immune-reactions in esophageal cancer patients who were given cancer vaccine and whose tumors co-express additional antigensPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immunomonitoring in head and neck cancer patients treated with protein vaccine through tumor destructionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Polyvalent cancer vaccine

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

がん遺伝子産物由来ペプチド抗原によるがん治療

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Book] Immunotyerapy of Cancer（分担）2016

Author(s)

Total Pages

Publisher

Data Source

[Book] がん免疫療法-実用化へのチャレンジ2010

Author(s)

Total Pages

Publisher

Data Source

[Book] がん免疫療法-実用化へのチャレンジ-2010

Author(s)

Publisher

Data Source

[Journal Article] Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high grade soft tissue sarcoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cancer immunotherapy using gene-engineered T cells2018

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination2018

Author(s)

Journal Title

Data Source

[Journal Article] Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy2017

Kageyama Shinichi 影山愼一

影山愼一カゲヤマシンイチ

KAGEYAMA Shinichi 影山愼一

影山慎一カゲヤマシンイチ